A phase II study of single agent bortezomib in patients with metastatic breast cancer: A single institution experience

Ryan H. Engel, Jennifer A. Brown, Jamie H. Von Roenn, Ruth M. O'Regan, Raymond Bergan, Sunil Badve, Alfred Rademaker, William J. Gradishar

Research output: Contribution to journal › Article › peer-review